Ausgabe 7/2016
Inhalt (13 Artikel)
Evidence-based clinical practice guidelines for liver cirrhosis 2015
Hiroshi Fukui, Hidetsugu Saito, Yoshiyuki Ueno, Hirofumi Uto, Katsutoshi Obara, Isao Sakaida, Akitaka Shibuya, Masataka Seike, Sumiko Nagoshi, Makoto Segawa, Hirohito Tsubouchi, Hisataka Moriwaki, Akinobu Kato, Etsuko Hashimoto, Kojiro Michitaka, Toshikazu Murawaki, Kentaro Sugano, Mamoru Watanabe, Tooru Shimosegawa
Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India
Saurabh Kedia, Ritika Rampal, Jaishree Paul, Vineet Ahuja
Genetic characteristics of inflammatory bowel disease in a Japanese population
Yuta Fuyuno, Keiko Yamazaki, Atsushi Takahashi, Motohiro Esaki, Takaaki Kawaguchi, Masakazu Takazoe, Takayuki Matsumoto, Toshiyuki Matsui, Hiroki Tanaka, Satoshi Motoya, Yasuo Suzuki, Yutaka Kiyohara, Takanari Kitazono, Michiaki Kubo
Detection of palisade vessels as a landmark for Barrett’s esophagus in a Western population
Dirk W. Schölvinck, Osamu Goto, Cornelis A. Seldenrijk, Raf Bisschops, Joichiro Horii, Yasutoshi Ochiai, Erik J. Schoon, Boudewijn E. Schenk, Toshio Uraoka, Martijn G. H. van Oijen, Jacques J. G. H. M. Bergman, Naohisa Yahagi, Bas L. A. M. Weusten
Aspirin-induced gastrointestinal damage is associated with an inhibition of epithelial cell autophagy
Carlos Hernández, Maria Dolores Barrachina, Jorge Vallecillo-Hernández, Ángeles Álvarez, Dolores Ortiz-Masiá, Jesús Cosín-Roger, Juan Vicente Esplugues, Sara Calatayud
Long-term outcomes after treatment for pedunculated-type T1 colorectal carcinoma: a multicenter retrospective cohort study
Naoki Asayama, Shiro Oka, Shinji Tanaka, Shinji Nagata, Akira Furudoi, Toshio Kuwai, Seiji Onogawa, Tadamasa Tamura, Hiroyuki Kanao, Yuko Hiraga, Hideharu Okanobu, Takayasu Kuwabara, Masaki Kunihiro, Shinichi Mukai, Eizo Goto, Fumio Shimamoto, Kazuaki Chayama
A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks
Dai Mohri, Hideaki Ijichi, Koji Miyabayashi, Ryota Takahashi, Yotaro Kudo, Takashi Sasaki, Yoshinari Asaoka, Yasuo Tanaka, Tsuneo Ikenoue, Keisuke Tateishi, Minoru Tada, Hiroyuki Isayama, Kazuhiko Koike
Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis
Sheng-li Yang, Li-ping Liu, Yun-fan Sun, Xing-rong Yang, Jia Fan, Jian-wei Ren, George G. Chen, Paul B. S. Lai
Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C
Goki Suda, Mineo Kudo, Atsushi Nagasaka, Ken Furuya, Yoshiya Yamamoto, Tomoe Kobayashi, Keisuke Shinada, Miki Tateyama, Jun Konno, Yoko Tsukuda, Kazushi Yamasaki, Megumi Kimura, Machiko Umemura, Takaaki Izumi, Seiji Tsunematsu, Fumiyuki Sato, Katsumi Terashita, Masato Nakai, Hiromasa Horimoto, Takuya Sho, Mitsuteru Natsuizaka, Kenichi Morikawa, Koji Ogawa, Naoya Sakamoto
Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis
Hidenori Toyoda, Takashi Kumada, Toshifumi Tada, Koichi Takaguchi, Toru Ishikawa, Kunihiko Tsuji, Mikio Zeniya, Etsuko Iio, Yasuhito Tanaka
Changing Nomenclature for PBC from “Primary Biliary Cirrhosis” to “Primary Biliary Cholangitis”
Atsushi Tanaka, Hajime Takikawa, Satoshi Mochida, Kazuhiko Koike, Hiroto Miwa, Toru Shimosegawa
Erratum to: Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis
Hidenori Toyoda, Takashi Kumada, Toshifumi Tada, Koichi Takaguchi, Toru Ishikawa, Kunihiko Tsuji, Mikio Zeniya, Etsuko Iio, Yasuhito Tanaka